Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities AVTX - Avalo Therapeutics, Inc.
-133 K
LAST VALUE
-8.49%
2 YEAR CAGR
-2.90%
5 YEAR CAGR
-16.34%
10 YEAR CAGR